Wanbond

Zhejiang Wanbond Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Wenling, China, specializing in the research, development, and production of modern Traditional Chinese Medicine (TCM) and chemical drugs. The company's core therapeutic focus lies in cardiovascular and cerebrovascular health, with a product portfolio led by Ginkgo Biloba Extract tablets and capsules. In addition to its TCM offerings, Wanbond manufactures a range of chemical generics targeting hypertension, angina, and respiratory conditions. The group operates multiple GMP-certified production lines and maintains a significant presence in the domestic Chinese healthcare market. Originally founded in 1970, the company has evolved into a key player in the regional pharmaceutical industry through continuous modernization of its manufacturing capabilities.